Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sharon Frierdich"'
Autor:
Julie Voeller, Chrysanthy Ikonomidou, Carol Diamond, Justin Brucker, Neha Patel, Sharon Frierdich
Publikováno v:
Child Neurology Open, Vol 5 (2018)
Child Neurology Open
Child Neurology Open
Neurologic dysfunction during acute lymphoblastic leukemia treatment is commonly associated with chemotherapy. Nonchemotherapy contributions should be considered for persistent atypical symptoms. We describe a boy with acute lymphoblastic leukemia wh
Publikováno v:
Journal of Pediatric Oncology Nursing. 23:220-232
Investigators have examined barriers to pain management in adults with cancer, but these patient-related barriers have rarely been studied in adolescents. This article summarizes 2 studies used in the development and initial psychometric testing of t
Publikováno v:
Family Relations. 51:103-111
Based on in-depth interviews with 42 parents (25 mothers, 17 fathers) in 26 families who had had a child treated for cancer within the previous 3 years, resiliency factors that helped the family recover were identified. The resiliency factors include
Autor:
Gregory H. Reaman, Sharon Frierdich, Mitchell S. Cairo, Julie Blatt, Bruce R. Blazar, Violet Shen, Mark Krailo, Wen Liu-Mares, Judith K. Sato, Madeline Bauer, James S. Miser
Publikováno v:
Journal of Pediatric Hematology/Oncology. 23:30-38
PurposeThe objectives of this study were[colon] 1) to compare the time to hematologic recovery (absolute neutrophil count [lsqb]ANC[rsqb] [ge]1,000/mm3 and platelet count [ge]100,000/mm3) in a randomized prospective study of two doses of granulocyte
Autor:
Peter M. Anderson, Bruce R. Blazar, Gregory H. Reaman, Paul M. Sondel, Robert C. Seeger, Jacek Gan, Ralph A. Reisfeld, Katherine K. Matthay, Mark Krailo, Mitchell S. Cairo, Jacquelyn A. Hank, Lawrence J. Ettinger, Sharon Frierdich, Jami D. Frost
Publikováno v:
Cancer. 80:317-333
BACKGROUND The murine monoclonal antibody (MoAb) 14.G2a recognizes GD2, a disialoganglioside expressed in tumors of neuroectodermal origin, and facilitates antibody dependent cellular cytotoxicity (ADCC) in vitro. When given in vivo, interleukin-2 (I
Autor:
Jacquelyn A. Hank, Gregory H. Reaman, Paul M. Sondel, Bruce R. Blazar, Peter L. Anderson, Madeline Bauer, Sharon Frierdich, Mitchell S. Cairo
Publikováno v:
Cancer. 75:2959-2965
Background. Recombinant human Interleukin-2 (IL-2) has been effective at inducing measurable antitumor responses in adults with renal cell carcinoma and melanoma. It also is being tested as adjuvant therapy for patients with acute myeloid leukemia af
Autor:
Margaret Morse, Jan Watterson, Yisheng Lee, John R. Priest, Michael Nieder, Sharon Frierdich, Christopher L. Moertel, I. Toogood
Publikováno v:
Cancer. 74:3034-3041
Background. Intrathecal chemotherapy, radiation therapy, and systemic chemotherapy are used for both prophylaxis and treatment of central nervous system (CNS) disease in hematologic malignancies. Twenty-three cases of myelopathy that occurred in pati
Autor:
Sharon Frierdich
Publikováno v:
Journal of Pediatric Oncology Nursing. 8:72-75
Publikováno v:
Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses. 20(5)
A survey directed to home care providers was conducted by the Children's Cancer Group Nursing Committee—Clinical Practice Group. The purpose of the survey was to (a) assess the treatments, resources, and counseling services provided to children wit
Autor:
Gregory H. Reaman, Paul M. Sondel, Wen Liu-Mares, Mark Krailo, Patricia A. Dinndorf, Sharon Frierdich
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 24(6)
Monoclonal antibodies, specific for antigens expressed on lymphoid malignancies, which have been conjugated to toxins such as ricin, hold promise in the therapy of childhood leukemia and lymphoma. Anti-B4-blocked ricin (anti-B4-bR) is such an agent,